VCYT
VERACYTE, INC.Company Information
- Company Name
- VERACYTE, INC.
- CIK
- CIK0001384101
- Category
- Large accelerated filer
- Ticker: Exchange
- VCYT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8071
- SIC Description
- Services-Medical Laboratories
- Ticker
- VCYT
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-21
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 501,056
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 87,672,385
- Shares outstanding
- 79,972,389
- Ownership
- 109.63%
Earnings Market Reaction
- Filing date
- 2026-07-31
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 300 | 263 | 363 | 316 | 219 | 186 | 239 | 274 | 236 | 209 | 216 | 202 | ||||||
| Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss | 186 | 176 | 50 | 51 | 101 | 101 | 50 | - | - | - | 0 | 0 | ||||||
| Accounts Receivable Net Current | 54 | 50 | 45 | 48 | 51 | 54 | 47 | 49 | 50 | 47 | 40 | 39 | ||||||
| Inventory Raw Materials And Supplies | 23 | 21 | 21 | 20 | 25 | 24 | 22 | 20 | 19 | 18 | 16 | 16 | ||||||
| Prepaid Expense And Other Assets Current | 13 | 12 | 10 | 15 | 18 | 18 | 15 | 14 | 16 | 16 | 13 | 14 | ||||||
| Assets Current | 575 | 522 | 488 | 449 | 415 | 383 | 372 | 357 | 321 | 290 | 286 | 271 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 22 | 23 | 22 | 19 | 19 | 23 | 23 | 21 | 22 | 22 | 21 | 19 | ||||||
| Operating Lease Right Of Use Asset | 35 | 36 | 37 | 37 | 39 | 48 | 48 | 17 | 18 | 11 | 10 | 11 | ||||||
| Intangible Assets Net Excluding Goodwill | 83 | 86 | 89 | 92 | 96 | 99 | 102 | 109 | 113 | 116 | 89 | 124 | ||||||
| Goodwill | 767 | 767 | 767 | 767 | 773 | 754 | 746 | 762 | 752 | 754 | 703 | 693 | ||||||
| Restricted Cash And Cash Equivalents Noncurrent | - | - | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Restricted Cash Noncurrent | 2 | 2 | 2 | - | - | - | 2 | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 3 | 1 | 1 | 1 | 1 | 7 | 7 | 8 | 7 | 6 | 6 | 6 | ||||||
| Assets | 1,486 | 1,436 | 1,406 | 1,368 | 1,344 | 1,315 | 1,300 | 1,275 | 1,234 | 1,200 | 1,115 | 1,125 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 8 | 7 | 5 | 6 | 11 | 16 | 9 | 10 | 12 | 12 | 13 | 13 | ||||||
| Accrued Liabilities Current | 48 | 43 | 49 | 48 | 44 | 36 | 44 | 44 | 43 | 30 | 38 | 35 | ||||||
| Contract With Customer Liability Current | 1 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | ||||||
| Business Combination Contingent Consideration Liability Current | 1 | 1 | 1 | 14 | 13 | 14 | 17 | 7 | 7 | 7 | 3 | 3 | ||||||
| Operating Lease Liability Current | 6 | 4 | 4 | 4 | 6 | 7 | 8 | 7 | 7 | 6 | 5 | 5 | ||||||
| Other Liabilities Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 63 | 56 | 60 | 72 | 76 | 75 | 79 | 70 | 72 | 58 | 61 | 57 | ||||||
| Deferred Income Tax Liabilities Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 34 | 35 | 36 | 36 | 44 | 43 | 43 | 12 | 14 | 8 | 8 | 9 | ||||||
| Other Liabilities Noncurrent | - | - | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Business Combination Contingent Consideration Liability | - | 1 | 0 | 1 | 1 | 1 | 1 | 14 | 14 | 13 | 1 | 0 | ||||||
| Liabilities | 98 | 92 | 96 | 110 | 123 | 120 | 124 | 99 | 102 | 81 | 71 | 71 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,720 | 1,701 | 1,695 | 1,685 | 1,671 | 1,660 | 1,656 | 1,646 | 1,627 | 1,617 | 1,536 | 1,528 | ||||||
| Retained Earnings Accumulated Deficit | -323 | -349 | -378 | -419 | -438 | -437 | -444 | -449 | -464 | -470 | -468 | -440 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -8 | -8 | -8 | -8 | -12 | -29 | -36 | -21 | -31 | -29 | -24 | -34 | ||||||
| Stockholders Equity | 1,388 | 1,344 | 1,310 | 1,258 | 1,221 | 1,195 | 1,176 | 1,176 | 1,133 | 1,119 | 1,044 | 1,054 | ||||||
| Liabilities And Stockholders Equity | 1,486 | 1,436 | 1,406 | 1,368 | 1,344 | 1,315 | 1,300 | 1,275 | 1,234 | 1,200 | 1,115 | 1,125 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | 125 | ||||||
| Common Stock Shares Issued | 80 | 80 | 79 | 79 | 79 | 78 | 78 | 77 | 77 | 76 | 73 | 73 | ||||||
| Shares Outstanding | 80 | 80 | 79 | 79 | 79 | 78 | 78 | 77 | 77 | 76 | 73 | 73 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVERACYTE, INC. (VCYT) — SEC Financial Statements & Analysis
VERACYTE, INC. (VCYT) is a services-medical laboratories company, incorporated in DE. VERACYTE, INC. trades on Nasdaq as: VCYT. VERACYTE, INC. (VCYT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-31. Based on that filing, VERACYTE, INC. carries a market cap of $4.70B, a P/E ratio of 41.03x, a P/B ratio of 3.38x, a P/S ratio of 8.36x, an enterprise value of $4.40B, and an EV/EBITDA multiple of 34.73x. On profitability, it posts a gross margin of 71.71%, an operating margin of 18.82%, a net margin of 20.37%, a Return on Equity (ROE) of 8.77%, a Return on Assets (ROA) of 8.09%, and a Return on Invested Capital (ROIC) of 9.89%. Per share, it reports EPS of $1.43, diluted EPS of $1.40, free cash flow per share of $2.08, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 17.28% year-over-year, net income growth of 334.72% year-over-year, and EPS growth of 326.12% year-over-year. On the balance sheet, it maintains a current ratio of 9.16x, a quick ratio of 8.96x, working capital of $512.04M, a debt-to-equity ratio of 0.07x, a debt ratio of 0.07, free cash flow of $165.99M (TTM), and net debt of $-299.52M. Figures sourced from SEC EDGAR.
- Market Cap
- $4.70B
- P/E TTM
- 41.03x
- EPS TTM
- $1.43
- P/B TTM
- 3.38x
- ROE TTM
- 8.77%
- ROA TTM
- 8.09%
- Debt To Equity
- 0.07x
- Free Cash Flow TTM
- $165.99M
- Net Revenue TTM Growth 1Y
- 17.28%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is VERACYTE, INC. in?
VERACYTE, INC. (VCYT) operates in the Services-Medical Laboratories industry.
What exchange does VCYT trade on?
VERACYTE, INC. (VCYT) trades on the Nasdaq.
Where is VERACYTE, INC. incorporated?
VERACYTE, INC. is incorporated in DE.
When was VERACYTE, INC. (VCYT)'s most recent SEC filing?
VERACYTE, INC. (VCYT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-31.
What is VCYT's market cap?
VERACYTE, INC. (VCYT) has a market capitalization of $4.70B as of 2026-06-30.
What is VCYT's P/E ratio?
VERACYTE, INC. (VCYT)'s trailing twelve month P/E ratio is 41.03x as of 2026-06-30.
What is VCYT's EPS (earnings per share)?
VERACYTE, INC. (VCYT)'s trailing twelve month EPS is $1.43 as of 2026-06-30.
What is VCYT's ROE (return on equity)?
VERACYTE, INC. (VCYT)'s trailing twelve month Return on Equity (ROE) is 8.77% as of 2026-06-30.
What is VCYT's ROA (return on assets)?
VERACYTE, INC. (VCYT)'s trailing twelve month Return on Assets (ROA) is 8.09% as of 2026-06-30.
What is VCYT's ROIC (return on invested capital)?
VERACYTE, INC. (VCYT)'s trailing twelve month Return on Invested Capital (ROIC) is 9.89% as of 2026-06-30.
What is VCYT's EV/EBITDA?
VERACYTE, INC. (VCYT)'s trailing twelve month EV/EBITDA is 34.73x as of 2026-06-30.